Congenital myopathies are a type of neuromuscular disorder that are present at birth or identified during childhood. They affect the structure and function of skeletal muscles, leading to muscle weakness that can range from mildly disabling to life-threatening. Congenital myopathies can be inherited or caused by genetic mutations, however there is no known cause in many cases. The most common type of congenital myopathy is called a congenital muscular dystrophy. This disorder causes progressive muscle weakness, scoliosis, and contractures of joints. Congenital muscular dystrophy occurs in both inherited and sporadic forms. Other types of congenital myopathies include central core disease, nemaline myopathy, and congenital fiber type disproportion. Most congenital myopathies present with symptoms of hypotonia, or muscle weakness, and can affect the muscles of the head and neck, the arms and legs, and the trunk and abdomen. Symptoms vary by type of myopathy and are typically progressive. Common features include difficulty with gross motor skills, difficulty with swallowing or feeding, abnormal walking, and a decreased ability to lift and hold objects. Diagnosing a congenital myopathy requires a physical examination and a variety of tests, such as electromyography, muscle biopsy, and genetic testing. While there is currently no cure for congenital myopathies, there are treatment options available to help manage symptoms and improve quality of life. Physical therapy, occupational therapy, and medications can help reduce pain and improve mobility. In some cases, surgery may be needed to correct spinal deformities. Living with a congenital myopathy can be difficult, but with the right support and resources, individuals with these conditions can lead active, healthy lifestyles. It is important to seek help from a medical team with expertise in neuromuscular disorders. With proper management, patients can live long and fulfilling lives.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom